PRESS DIGEST- Financial Times - December 12

Reuters
Dec 12
PRESS DIGEST- Financial Times - December 12

Dec 12 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headlines

- Lululemon shares jump after chief Calvin McDonald announces departure

- Crypto founder Do Kwon sentenced to 15 years in prison

- Disney to invest $1 billion in OpenAI

- Natixis and Generali end talks over asset management tie-up

- Eli Lilly shot helped patients lose 29% of body weight

Overview

- Lululemon's LULU.O chief executive plans to step down at the end of January, the Canadian activewear manufacturer said, adding that it had kicked off a search for a new CEO to take over from Calvin McDonald, who will continue as a senior adviser until the end of March.

- Cryptocurrency entrepreneur Do Kwon has been sentenced to 15 years in prison on two counts of fraud, after the collapse of the TerraUSD and luna tokens he controlled caused investors to lose more than $40 billion.

- Walt Disney DIS.N has agreed to invest $1 billion in OpenAI as part of a deal that will allow the artificial intelligence start-up to use Disney's characters in its flagship products.

- The owners of France's Natixis Investment Managers and Italian insurer Generali GASI.MI ended agreement to create a European asset management champion, saying that they had "jointly taken the decision to terminate negotiations."

- Eli Lilly's LLY.N latest weight-loss shot helped patients lose as much as 29% of their body weight in trials, Lilly said that the drug, called retatrutide, also improved other measures of physical wellbeing, with one in eight patients completely free from knee pain at the end of the trial.

(Compiled by Bengaluru newsroom)

((globalnewsmonitoring@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10